Posted in | News

Trimble and CREEC Enter Deal to Form Joint Venture in China

Trimble (Nasdaq: TRMB) and the China Railway Eryuan Engineering Group Co. Ltd. (CREEC) announced today that they have signed a definitive agreement to form a joint venture in China.

The joint venture, 50 percent owned by Trimble and 50 percent owned by CREEC, will leverage Trimble's commercial positioning, communications and software technologies and CREEC's expertise in rail design and construction to develop and provide digital railway solutions that address the design, construction and maintenance for the Chinese railway industry.

The joint venture will be based in Chengdu, China and is expected to begin operations after regulatory approval from the Chinese government.

"The next stage of China's railway development will embrace digital solutions, which require higher standards in survey, design and construction and creates new opportunities at the same time. Thus, the cooperation between the two parties is in line with the long-term development strategy under such prospects," said Qi Baorui, chairman of CREEC.

"We are extremely pleased to be partnering with CREEC, a world leader in railway design and management," said Steven W. Berglund, Trimble president and CEO. "With China's rate of economic development and modernization, infrastructure projects in the area of transportation are national priorities. By leveraging our respective capabilities, we believe the joint venture will create innovative digital solutions that will increase efficiency and productivity for the railway industry."

Source: http://www.trimble.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.